CANCER THERAPY
SYNCROMUNE® IS AT THE FOREFRONT OF DEVELOPING NEW IMMUNOTHERAPIES DESIGNED TO HELP PATIENTS WHO PREVIOUSLY HAD LIMITED TREATMENT OPTIONS. OUR DESIRE TO DEVELOP SOLUTIONS FOR PATIENTS WITH UNMET NEEDS DRIVES US EVERY DAY.
®
CANCER THERAPY
®
SYNCROMUNE® IS AT THE FOREFRONT OF DEVELOPING NEW IMMUNOTHERAPIES DESIGNED TO HELP PATIENTS WHO PREVIOUSLY HAD LIMITED TREATMENT OPTIONS. OUR DESIRE TO DEVELOP SOLUTIONS FOR PATIENTS WITH UNMET NEEDS DRIVES US EVERY DAY.
PATIENT RESOURCES
The following are additional resources to learn more about immunotherapy, SYNC-T's™ initial indications (metastatic non-small cell lung cancer, breast, and prostate), as well as current SYNC-T™ trials.
Disclaimers: The content on this website is intended for US healthcare professionals only. The compounds and their uses mentioned on this website are investigational and have not been determined safe and effective by the US Food and Drug Administration.
